Drug Research

Research conducted by Wolters Kluwer, an information and software company, suggests that artificial intelligence (AI) can potentially reduce drug diversion in hospitals. The study revealed that over half of managers who implemented AI-based diversion detection programs reported increased confidence...

Sygnature Discovery (Sygnature) is delighted to announce that its customer, River BioMedics, has raised an additional €2M in seed funding to continue its life-saving cardiovascular drug research. Libertatis Ergo Holding, an independent subsidiary of Leiden University joins the investment syndicate...

 Following the signature of a multi-year large scale peptide manufacturing agreement earlier this year, CordenPharma is pleased to announce the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide. After kicking off capital investments in early 2023, CordenPharma successfully completed a series of upgrades and modernizations to the...

Torx Software Limited, announces a collaboration with CDD Vault to facilitate the seamless synthesis and registration of new compounds during the small-molecule drug discovery process. Torx is a cloud-based platform developed by Cresset and Elixir™ Software, which enables chemistry teams...

The United Kingdom has once again become a part of Horizon Europe through a fresh agreement with the European Union. This development opens up opportunities for British scientists to engage in the world's largest research and development collaboration program....

The UK government dedicates £5.5 million towards establishing a Medicines Manufacturing Skills Centre of Excellence. This center aims to bolster the pool of skilled individuals in the UK's life sciences sector, fostering innovation and enabling the country to respond...

Global contract development and manufacturing organisation (CDMO) Recipharm is partnering with Ahead Therapeutics to develop a ground-breaking treatment for a rare autoimmune disease, myasthenia gravis. Ahead Therapeutics is a Spanish start-up biotech company, using proprietary technology to develop treatments for different autoimmune disorders. Under...